These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3303314)

  • 1. [Hypertensive crisis after withdrawal of clonidine and nadolol. Case report and review of the literature].
    Fried M; Schwander J
    Schweiz Med Wochenschr; 1987 Jun; 117(23):874-8. PubMed ID: 3303314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebound hypertension following abrupt cessation of clonidine and metoprolol. Treatment with labetalol.
    Mehta JL; Lopez LM
    Arch Intern Med; 1987 Feb; 147(2):389-90. PubMed ID: 3813760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA; Brown JJ; Lever AF; Robertson AS; Robertson JI; Trust PM
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal syndrome following cessation of antihypertensive drug therapy.
    Karachalios GN; Charalabopoulos A; Papalimneou V; Kiortsis D; Dimicco P; Kostoula OK; Charalabopoulos K
    Int J Clin Pract; 2005 May; 59(5):562-70. PubMed ID: 15857353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal syndromes and the cessation of antihypertensive therapy.
    Hart GR; Anderson RJ
    Arch Intern Med; 1981 Aug; 141(9):1125-7. PubMed ID: 6114720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension.
    Strauss FG; Franklin SS; Lewin AJ; Maxwell MH
    JAMA; 1977 Oct; 238(16):1734-6. PubMed ID: 578267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
    Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP
    Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension after clonidine withdrawal.
    Husserl FE; deCarvalho JG; Batson HM; Frohlich ED
    South Med J; 1978 May; 71(5):496-7. PubMed ID: 644354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative and postoperative use of clonidine with neurolept anaesthesia.
    Kaukinen S; Kaukinen L; Eerola R
    Acta Anaesthesiol Scand; 1979 Apr; 23(2):113-20. PubMed ID: 442942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regimen for the control of blood pressure and symptoms during clonidine withdrawal.
    Campbell BC; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of labetalol in hypertensive patients during discontinuation of clonidine therapy.
    Rosenthal T; Rabinowitz B; Boichis H; Elazar E; Brauner A; Neufeld HN
    Eur J Clin Pharmacol; 1981; 20(4):237-40. PubMed ID: 6273179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clonidine-diuretic combination in patients with essential hypertension. Modification of sympathetic activity and blood pressure as well as the reaction following sudden withdrawal].
    Beckenbauer UE; Planz G
    Fortschr Med; 1984 Aug; 102(31-32):802-6. PubMed ID: 6479820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebound hypertension after discontinuation of transdermal clonidine.
    Schmidt GR; Schuna AA
    Clin Pharm; 1988 Oct; 7(10):772-4. PubMed ID: 3233898
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of transdermal clonidine in the hypertensive patient with chronic renal failure.
    Lowenthal DT; Saris SD; Paran E; Cristal N
    Clin Nephrol; 1993 Jan; 39(1):37-43. PubMed ID: 8428406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clonidine abstinence syndrome. A clinical case].
    Vignali G; Guadagnucci A; Tulli G
    Minerva Med; 1990 Sep; 81(9):645-7. PubMed ID: 2234489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications following withdrawal of antihypertensive drugs. I. Hypertensive rebound phenomenon].
    Laham E
    Sem Hop; 1979 Nov 18-25; 55(39-40):1811-6. PubMed ID: 232778
    [No Abstract]   [Full Text] [Related]  

  • 19. Rebound hypertension associated with transdermal clonidine and contact dermatitis.
    White TM; Guidry JR
    West J Med; 1986 Jul; 145(1):104. PubMed ID: 3751022
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperkalemia associated with intravenous labetalol therapy for acute hypertension in renal transplant recipients.
    Arthur S; Greenberg A
    Clin Nephrol; 1990 Jun; 33(6):269-71. PubMed ID: 2376088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.